RPL5P28

Across TCGA pan-cancer cohorts, RPL5P28 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL5P28 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPL5P28 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL5P28 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LGG show a favorable association.

OV, ACC, and LUAD are the cancer types where RPL5P28 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.258	0.372	.005	40	view →
ACC	DFS	Tertile	All	0.280	0.772	<.001	38	view →
LUAD	OS	Tertile	III,IV	0.317	0.692	.003	37	view →
BLCA	OS	Median	II,III,IV	0.523	0.345	.007	36	view →
UVM	DFS	Median	III,IV	0.377	0.696	.007	23	view →
SARC	OS	Tertile	All	0.658	0.796	.003	19	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
LGG	OS	Quartile	All	0.698	0.389	.001	16	view →
READ	DFS	Tertile	IV	0.737	0.343	.014	13	view →
CESC	OS	Quartile	All	0.834	0.506	.007	8	view →
THCA	OS	Median	II,III,IV	0.964	0.751	.021	7	view →
LIHC	OS	Tertile	III,IV	0.194	0.443	.007	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPL5P28–OV (OS)

Open the OV breakdown →